Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹2,578Cr
Rev Gr TTM
Revenue Growth TTM
21.45%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

MEDIASSIST
VS
| Quarter | Mar 2023 | Jun 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | | | | 32.3 | 22.6 | 19.1 | | 12.0 | 13.2 | 13.6 | 28.6 | 28.9 |
| 95 | 105 | 118 | 132 | 130 | 132 | 142 | 146 | 148 | 149 | 193 | 195 |
Operating Profit Operating ProfitCr |
| 24.5 | 22.6 | 15.9 | 20.4 | 22.2 | 21.0 | 21.3 | 21.3 | 21.6 | 22.1 | 17.1 | 18.6 |
Other Income Other IncomeCr | 6 | 3 | 5 | 4 | 4 | 5 | 6 | 4 | 8 | 7 | 2 | -7 |
Interest Expense Interest ExpenseCr | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 4 | 5 | 8 | 8 |
Depreciation DepreciationCr | 6 | 8 | 8 | 11 | 12 | 14 | 14 | 14 | 14 | 14 | 21 | 21 |
| 30 | 25 | 18 | 26 | 28 | 25 | 29 | 27 | 30 | 31 | 13 | 8 |
| 9 | 8 | 1 | 4 | 3 | 6 | 9 | -3 | 8 | 8 | 5 | 4 |
|
Growth YoY PAT Growth YoY% | | | | -1.6 | 61.0 | 6.1 | | 41.5 | -15.4 | 19.4 | -61.6 | -86.2 |
| 17.2 | 11.7 | 12.7 | 12.8 | 15.3 | 11.3 | 11.6 | 16.1 | 11.4 | 11.9 | 3.5 | 1.7 |
| 3.4 | 2.0 | 2.6 | 3.0 | 3.6 | 2.7 | 3.0 | 4.2 | 3.0 | 3.2 | 1.1 | 0.5 |
| Financial Year | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 19.4 | 15.1 | 1.3 | 22.0 | 28.2 | 25.7 | 14.0 | 17.7 |
| 156 | 194 | 237 | 247 | 303 | 386 | 501 | 569 | 685 |
Operating Profit Operating ProfitCr |
| 32.9 | 29.8 | 25.7 | 23.5 | 23.2 | 23.6 | 21.0 | 21.3 | 19.6 |
Other Income Other IncomeCr | 10 | -7 | 12 | 23 | 21 | 14 | -3 | 24 | 11 |
Interest Expense Interest ExpenseCr | 4 | 4 | 4 | 6 | 3 | 3 | 3 | 10 | 25 |
Depreciation DepreciationCr | 19 | 23 | 27 | 32 | 28 | 27 | 43 | 56 | 70 |
| 64 | 48 | 63 | 61 | 81 | 104 | 84 | 112 | 83 |
| 20 | 15 | 24 | 23 | 17 | 28 | 13 | 20 | 26 |
|
| | -24.9 | 18.8 | -3.0 | 67.0 | 18.7 | -5.3 | 28.5 | -38.4 |
| 18.9 | 11.9 | 12.3 | 11.8 | 16.1 | 14.9 | 11.2 | 12.7 | 6.6 |
| 6.0 | 3.9 | 5.2 | 3.9 | 9.3 | 10.8 | 9.7 | 12.9 | 7.9 |
| Financial Year | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 0 | 0 | 0 | 0 | 34 | 34 | 35 | 35 | 35 |
| 204 | 218 | 212 | 248 | 258 | 301 | 398 | 468 | 544 |
Current Liabilities Current LiabilitiesCr | 229 | 255 | 302 | 219 | 234 | 279 | 319 | 504 | 628 |
Non Current Liabilities Non Current LiabilitiesCr | 44 | 46 | 42 | 34 | 29 | 44 | 50 | 102 | 201 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 267 | 283 | 308 | 372 | 427 | 442 | 478 | 751 | 615 |
Non Current Assets Non Current AssetsCr | 213 | 237 | 250 | 174 | 175 | 264 | 373 | 407 | 805 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 40 | 35 | 19 | 139 | 64 | 81 | 66 | 138 |
Investing Cash Flow Investing Cash FlowCr | -42 | -21 | -22 | -61 | -83 | -10 | -55 | -218 |
Financing Cash Flow Financing Cash FlowCr | -7 | -10 | -12 | -10 | -30 | -32 | -15 | 112 |
|
Free Cash Flow Free Cash FlowCr | 28 | 21 | 6 | 127 | 67 | 53 | 49 | 92 |
| 91.6 | 106.2 | 47.6 | 366.9 | 101.5 | 107.7 | 93.1 | 150.8 |
CFO To EBITDA CFO To EBITDA% | 52.7 | 42.5 | 22.8 | 184.1 | 70.6 | 67.9 | 49.8 | 89.6 |
| Financial Year | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 0 | 0 | 0 | 0 | 0 | 3,548 | 3,205 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 53.0 | 35.3 |
Price To Sales Price To Sales | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.6 | 4.4 |
Price To Book Price To Book | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 8.2 | 6.4 |
| 1.1 | 1.0 | 0.9 | -1.1 | -0.4 | -1.5 | 25.6 | 20.9 |
Profitability Ratios Profitability Ratios |
| 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| 32.9 | 29.8 | 25.7 | 23.5 | 23.2 | 23.6 | 21.0 | 21.3 |
| 18.9 | 11.9 | 12.3 | 11.8 | 16.1 | 14.9 | 11.2 | 12.7 |
| 22.4 | 16.6 | 20.5 | 23.6 | 26.2 | 29.1 | 19.1 | 17.3 |
| 21.5 | 15.1 | 18.4 | 15.3 | 21.7 | 22.5 | 16.5 | 18.2 |
| 9.1 | 6.3 | 7.0 | 7.0 | 10.5 | 10.7 | 8.4 | 7.9 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Overview**
Medi Assist Healthcare Services Ltd is India’s largest and most advanced **Health Benefits Administrator (HBA)**, evolving from a traditional Third-Party Administrator (TPA) into a technology-led, full-spectrum provider of end-to-end health benefits solutions. The company operates across group, retail, government (SAHI), and international private medical insurance (IPMI) segments, serving insurers, corporates, government programs, healthcare providers, and policyholders. With a pan-India presence and global reach through its Mayfair We Care subsidiary, Medi Assist is at the forefront of digital innovation in health insurance administration.
---
### **Recent Strategic Developments (Nov 2025)**
#### **Market Expansion & International Growth**
- **Mayfair We Care**, Medi Assist’s international arm, onboarded **one Indian and one UK insurer** in the **IPMI and group insurance segments**, strengthening its global footprint.
- A **strategic partnership with Bhutan’s Royal Insurance Corporation** was activated, enabling Bhutanese policyholders to access **cashless treatment** at Medi Assist’s extensive provider network across India.
- **Mayfair We Care UK** added new clients in individual portable medical insurance (IPMI) and group segments, with over 60% of legacy policies migrated to the **MAven Global IPMI platform**, enhancing cross-border claims processing, multi-currency support, and member experience.
#### **Technology & Innovation**
- Announced an **industry-first partnership with Star Health & Allied Insurance** to deploy **MAtrix**, Medi Assist’s AI-powered claims processing platform. Full-scale deployment was achieved in **under six months**, with **40% of Star Health’s claims volume** already processed on the platform.
- Delivered **₹230 crore in fraud, waste, and abuse (FWA) savings in H1-FY26**, a **50% YoY increase**, driven by advanced AI analytics and proprietary detection systems.
- Launched **‘MAven Guard’**, a new AI/ML-based **standalone fraud detection engine**, available as a SaaS offering to insurers for enhanced FWA prevention.
#### **Operational Performance & Digital Enablement**
- **Raksha Prime**, the AI-powered instant discharge solution, facilitated **156,000 discharges in H1-FY26**, up from 38,000 in H1-FY25, showcasing rapid adoption and improved patient experience.
- **MAtrix platform** processed approximately **52 lakh claims in H1-FY26**, representing a **26% YoY increase**, demonstrating scalability and growing reliance by insurers.
- Technology investments continue at **5–7% of revenue (semi-annually)**, underscoring sustained commitment to digital infrastructure and innovation.
---
### **Core Business Model & Strategic Shift**
#### **From TPA to Health Benefits Administrator (HBA)**
Medi Assist has transitioned from a claims processor to a **full-fledged HBA**, offering modular, unbundled services across the health benefits value chain:
- End-to-end **claims adjudication** (cashless authorization in <1 hour, discharge in <3 hours)
- **Provider network management** with negotiated tariffs and quality assurance
- AI-driven **fraud, waste, and abuse (FWA) detection**
- **Real-time analytics and reporting** (MAven Insights)
- **International benefits administration (IPMI)** via Mayfair We Care
- **Personalized digital health journeys** and omnichannel member support
This **modular service architecture** allows insurers and corporates to adopt specific capabilities (e.g., fraud detection, network access) on a **plug-and-play basis**, increasing flexibility and expanding Medi Assist’s addressable market.
---
### **Provider Network & Cost Efficiency**
- Operates a curated **PAN India provider network of 20,204 hospitals across 1,217 cities**, with **exclusive adoption by 19 insurers** in H1-FY26 (up from 17 YoY).
- **Average claim size growth of 4.4%** in H1-FY26—significantly below the industry medical inflation rate of **10–12%**—demonstrating strong cost control via network curation, analytics, and AI-driven pricing.
- Leverages scale and data intelligence to **reduce medical inflation**, insurer **loss ratios**, and **out-of-pocket expenses** for policyholders.
---
### **Technology Leadership & Platforms**
| Platform | Function |
|--------|--------|
| **MAtrix** | AI-powered end-to-end claims processing engine; handles 22–30 lakh claims per quarter; integrated with NHCX and ABDM for paperless, consent-based claims. |
| **MAven Insights** | Predictive analytics engine for cost forecasting, fraud detection, and real-time dashboards. |
| **Raksha Prime** | AI/ML-based instant discharge solution; enabled **175,000+ express discharges in FY25**; reduced discharge wait times significantly. |
| **MAven Navigator** | Predicts out-of-pocket costs pre-hospitalization using policy, hospital, and treatment data—**market unique**. |
| **MAven Guard / FDE** | AI-driven fraud detection engine with **60–70% hit rate** (vs. 2–4% historically); saved ₹390 crore+ in FY25. |
---
### **Consolidation & Acquisition Strategy**
#### **Paramount TPA Acquisition Completed (Jul 2025)**
- Full acquisition of **Paramount Health Services & Insurance TPA** finalized, making Medi Assist the **undisputed market leader** in India’s HBA space.
- Adds **₹4,000 crores of health premiums under administration** and expands insurer and provider relationships.
- Combined entity held **~23.6% market share** in health insurance premiums in FY24, with **36% dominance in group health**.
- Integration underway over 4–5 quarters, focused on **technology harmonization**, **operational synergies**, and **margin optimization**.
- Expected to add **₹140+ crores in annual revenue** (IndAS basis); temporary margin impact of **200–250 bps** expected post-integration.
#### **Proven Track Record of Integration**
Past acquisitions (Raksha, Medvantage, Mayfair We Care) strengthened retail presence, corporate portfolios, and global capabilities, with consistent improvements in automation, profitability, and client retention.
---
### **Global & Government Business Growth**
#### **International Operations (Mayfair We Care)**
- Serves **185+ countries**, with access to **500,000+ global providers**.
- **35.6% YoY revenue growth** in FY25; active membership up **71% YoY**.
- Key partner for **Indian corporates with international operations**, **global insurers**, and **mobile populations** (e.g., seafarers).
- Offers **multi-currency, cross-border benefits administration**, aligning with rising outbound travel and medical tourism.
#### **Government Health Programs**
- Expanding role in **PMJAY and state-level SAHI schemes**, serving ~60% of India’s population under public health coverage.
- Government segment revenue grew **>24% YoY from FY24 to FY25**, with improving margin quality.
- Positioned as the **execution backbone** for public insurance programs, supporting the national vision of **"Insurance for All by 2047."**
---
### **Market Position & Competitive Advantage**
- **Market Leadership**:
- **30.3% share in group health** insurance administration.
- **5.7% in retail health**, with potential for post-acquisition expansion.
- **Diversified Revenue Streams**: TPA fees, technology (SaaS), international services, government administration, and value-added services.
- **High Barriers to Entry**: Proprietary tech, exclusive networks, data moats, and deep insurer relationships.
- **Asset-Light Model with Negative Working Capital**: Supported by advance insurer payments and strong cash flows; low reinvestment needs.
---
### **Financial & Operational Highlights (Latest Data)**
- **Claims Processed (H1-FY26)**: ~52 lakh (26% YoY growth)
- **Raksha Prime Discharges (H1-FY26)**: 156,000 (vs. 38,000 in H1-FY25)
- **FWA Savings (H1-FY26)**: ₹230 crores (+50% YoY)
- **Technology Investment**: 5–7% of revenue (semi-annual)
- **Client Retention Rate**: ~95% across group and retail
- **Operating Cash Flow (FY25)**: ₹1,380.9 million
- **Cash Reserves (FY25)**: ₹3,122.4 million